PNC Financial Services Group’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-98
| Closed | -$241 | – | 4726 |
|
|
2023
Q2 | $241 | Sell |
98
-1,762
| -95% | -$4.33K | ﹤0.01% | 4654 |
|
|
2023
Q1 | $4.2K | Buy |
1,860
+1,586
| +579% | +$3.59K | ﹤0.01% | 4094 |
|
|
2022
Q4 | $956 | Buy |
274
+197
| +256% | +$687 | ﹤0.01% | 4418 |
|
|
2022
Q3 | $3K | Buy |
77
+64
| +492% | +$2.49K | ﹤0.01% | 4104 |
|
|
2022
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 4677 |
|
|
2022
Q1 | $0 | Buy |
+13
| New | – | ﹤0.01% | 4676 |
|